A recent Polish study reported on the predictive ability of CX3CL1 as a biomarker in the early development of mild cognitive impairment (MCI) and Alzheimer’s disease [37]. The gene discussed is CX3CL1; the disease is early-onset autosomal dominant Alzheimer disease.